Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,229 total articles
Greenbrier (GBX) looks like a reasonable swing trade and position-buy after recent earnings beats, dividend increases and improving industry signals. Valuation is attractive (P/E ~13.3, P/B ~0.91), enterprise value is reasonable relative to EBITDA (EV/EBITDA 10.47), and the company has resumed dividend growth. Enter with a defined stop and modest p…
SOYB is trading near its 52-week high on rising momentum, a compressed float, and renewed geopolitical premium tied to shipping through the Strait of Hormuz. I lay out a mid-term (45 trading days) actionable long with concrete entry, stop, and target and explain the catalysts and risks that justify the stance.
FNCNF has begun to grind higher after bottoming above its 50-day moving average. With neutral RSI, EMAs converging and short interest still elevated but trending down from earlier peaks, there’s a tactical long opportunity for a disciplined, mid-term trade. Illiquidity and mixed momentum mean tight risk controls are essential.
Orrstown Financial Services shows low leverage, solid cash flow and a cheap P/E today. Combine a recent move to reduce debt with merger integration tailwinds and a 2.7% yield, and you have a reasonable risk/reward for a swing trade. Entry, stop and target provided with time-horizon rationale.
Wolfspeed (WOLF) is battered after a missed quarter and negative margins, but the stock sits at a valuation that prices in significant execution risk. This trade idea outlines a defined-risk, mid-term swing long with a $25.30 entry, $22.00 stop loss and a $34.00 target, sized for investors willing to stomach high volatility and a potentially binary…
Huron (HURN) is a profitable, data-and-technology-enabled consulting firm with a $2.53B market cap, $161M of free cash flow and a 30% return on equity. Recent price action has pulled the stock off its 52-week lows and momentum indicators look constructive. We outline a mid-term swing trade to capture a re-rating back toward recent highs while keepi…
International Business Machines (IBM) remains a competent cash-flow engine with meaningful exposure to enterprise AI and hybrid cloud. At $234.16, the stock offers a 2.9% yield, $13.8B in free cash flow and a valuation that prices growth but leaves room for re-rating if enterprise AI adoption accelerates. This trade lays out entry, stop and target …
RTX (RTX) is a market-leading aerospace and defense integrator trading at $210.50 with a $283.4B market cap. Management is guiding 2026 adjusted sales of $95-96B and the company reports a $289B backlog - a multi-year revenue runway that supports earnings visibility, cash generation and shareholder returns. Valuation is rich versus the broader marke…
Mastercard combines durable TPV growth, exceptional free cash flow generation and operating leverage with a valuation that still leaves room for upside. At roughly $525B market cap and trading near $599, the stock offers a risk/reward profile worth a measured long position with a clear entry, stop and target for a long-term trade (180 trading days)…
SoFi is starting to look less like a growth story priced for perfection and more like a profitable fintech platform executing a clear cross-sell playbook. With 1.1M net new members last quarter, $1.2B in revenue and growing adjusted net income, the setup favors a controlled long trade: entry $19.01, target $26.00, stop $16.50. Technical momentum, l…
Rumble's acquisition of Northern Data adds ~22,000 NVIDIA GPUs, 200+ MW of energy capacity and a $270M contract with Together AI. The setup creates a plausible path to materially larger revenue, but the stock trades at a steep multiple and faces execution, cash burn and legal risks. This is a tactical long with clearly defined entry, stop and targe…
ACV Auctions (ACVA) is seeing unusual options flow and elevated short activity while fundamentals show improving revenue and margin expansion. The mix creates an asymmetric swing trade: play a measured long with a clear stop below $6 and a stretch target near the 52-week high if positive catalysts arrive.
Blue Bird (BLBD) looks like a high-conviction trade after a sharp pullback. The company trades at ~ $1.86B market cap with a P/E below 7, strong free cash flow ($153M), and balance sheet leverage under 0.2x. Technicals are oversold (RSI ~29) and short interest is meaningful, setting up a squeezed rebound if incremental commercial EV wins materializ…
Unifi is a small-cap polyester and nylon recycler trading on deep multiples of cash flow rather than earnings. With a market cap near $139M, free cash flow of $16.63M and an enterprise value of roughly $210.5M, management has room to materially reduce net debt. If textile-recycling demand and pricing continue to improve, the stock can re-rate from …
Marvell plunged roughly 23% from recent highs before retracing into the $240 area. The business sits squarely in AI infrastructure, custom silicon and optical networking - areas with strong secular tailwinds. Fundamentals (market cap ~$210.5B, positive free cash flow, ROE ~13.9%) and short covering dynamics support a recovery. We rate this a strong…
Atlassian just ripped higher on GAAP profitability and AI-driven product adoption even as management trimmed growth guidance. The market is rewarding margins and Rovo-driven cloud uptake; technicals show momentum but the name is overbought and still carries valuation and execution risk. This is a tactical long with a clear entry, stop and target de…
Comfort Systems USA (FIX) stands squarely in the crosshairs of the AI data-center buildout. With a backlog north of $14B, outsized cash generation and a conservative balance sheet, the company can meaningfully outgrow the broader construction cycle this year. Valuation is premium, but the risk/reward looks attractive from current levels for a long-…
Polaris (PII) is a cash-generative recreational products franchise with a 4.2% yield, a large addressable UTV/marine market tailwind and recent operational wins that should support a multi-month recovery. The stock is trading below key moving averages and at a sub-1x price-to-sales multiple. We lay out an actionable long trade with entry, stop and …
Tuya ($1.76) looks set to benefit from accelerating adoption of its AI Agent and Hey Tuya assistant, improving technical momentum, and a sub-$1.1B market cap that leaves room for a re-rating if growth steadies. This trade idea lays out an actionable entry at $1.76, a stop at $1.59, and a target of $2.40 over a mid-term 45 trading day horizon, with …
Supermicro (SMCI) has been hit hard but the core business - high-performance servers and AI-optimized systems - still sits on a favorable secular runway. With shares well off prior highs and a rebound in AI spending increasingly visible, this is a tactical long idea for disciplined traders willing to accept execution risk and near-term cyclicity.
KLA is uniquely exposed to the semiconductor equipment sweet spot driving capital spending into 2027: metrology/inspection for advanced packaging and a multi-year memory/AI-capex cycle. Strong free cash flow ($3.77B), exceptional ROE (76%), and an improving revenue mix justify a long-term swing trade, even after a high P/E. Enter around $183, stop …
<p>CoreWeave is positioned as a high-growth GPU cloud specialized for AI workloads. Recent pricing action from Nvidia that raises GPU list prices is widely seen as a headwind for cloud users and smaller GPU resellers. I argue it can be a net positive for CoreWeave: price hikes favor providers with scale, deep vendor relationships, and differentiate…
Fiserv (FISV) trades at ~10x earnings and an EV/EBITDA of ~7.2 with free cash flow near $3.93B. Recent activist involvement, a CEO transition, and possible asset monetizations (including the Clover business) create a clear path to earnings upside and multiple expansion. I favor a long trade at current levels with a $75 target over the next 180 trad…
Immatics (IMTX) is a clinical-stage TCR developer with anzu-cel (IMA203) nearing a regulatory milestone: the Phase 3 SUPRAME program is on track for a BLA submission in H1 2027. Recent Phase 1b data showed a 56% confirmed ORR and durable responses, supporting a binary catalyst that could re-rate the $1.25B market-cap equity. This trade sets a clear…
Compass Pathways (CMPS) is a high-volatility biotech with positive Phase 3 data and favorable regulatory momentum in 2026. The stock trades near $14.86 with a market cap around $2.0B. This trade idea outlines a mid-term swing long (45 trading days) with an entry at $14.86, stop at $11.50, and a target of $20.00 while mapping the clinical, regulator…
